Compare NEO & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEO | AZTA |
|---|---|---|
| Founded | 2001 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2008 | 1996 |
| Metric | NEO | AZTA |
|---|---|---|
| Price | $7.90 | $21.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $11.14 | ★ $42.60 |
| AVG Volume (30 Days) | ★ 2.0M | 716.5K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $593,821,000.00 |
| Revenue This Year | $10.63 | $6.25 |
| Revenue Next Year | $9.73 | $5.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.72 | $21.34 |
| 52 Week High | $13.74 | $41.73 |
| Indicator | NEO | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 19.28 | 19.33 |
| Support Level | $7.07 | N/A |
| Resistance Level | $8.89 | $31.87 |
| Average True Range (ATR) | 0.47 | 1.01 |
| MACD | -0.11 | -0.23 |
| Stochastic Oscillator | 2.30 | 1.48 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.